Ajax-Loading

Astellas Pharma Inc. - Long Term Investments

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Long-Term-Investments" stands at 127.46 Billion Japanese Yens as of 12/31/2019, the highest value at least since 06/30/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.39 percent compared to the value the year prior.
The 1 year change in percent is 16.39.

The Serie's long term average value is 110.82 Billion Japanese Yens. It's latest available value, on 12/31/2019, is 15.01 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2018, to it's latest available value, on 12/31/2019, is +50.10%.
The Serie's change in percent from it's maximum value, on 12/31/2019, to it's latest available value, on 12/31/2019, is 0.0%.

Long Term Investments for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Long Term Investments905,699,262,464.00
LogoJohnson & Johnson - Long Term Investments486,508,953,600.00
LogoAbbVie Inc - Long Term Investments399,570,305,024.00
LogoRoche Holding AG - Long Term Investments317,433,206,677.55
LogoAstraZeneca PLC - Long Term Investments280,205,508,085.11